Welcome to our dedicated page for Ingevity news (Ticker: NGVT), a resource for investors and traders seeking the latest updates and insights on Ingevity stock.
Ingevity Corporation (NYSE: NGVT) is a specialty materials and chemical manufacturer that reports its operations through three segments: Performance Materials, Advanced Polymer Technologies and Performance Chemicals. News about NGVT often centers on how these businesses evolve, how the portfolio is being reshaped and how the company’s products are used in demanding applications such as adhesives, agrochemicals, asphalt paving, certified biodegradable bioplastics, coatings, elastomers, pavement markings, lubricants, oil drilling and automotive components.
Investors following Ingevity news can expect frequent updates on segment performance, portfolio actions and strategic direction. Recent announcements include the agreement and subsequent completion of the sale of the North Charleston crude tall oil refinery and the majority of the Performance Chemicals Industrial Specialties product line to Mainstream Pine Products, LLC. The company has characterized this divestiture as a way to reduce portfolio volatility, strengthen margins and cash flow and focus on higher-margin specialty applications in activated carbon and pavement or road technologies.
Ingevity has also reported on its portfolio review process and its decision to explore strategic alternatives for the Advanced Polymer Technologies segment and the Performance Chemicals Road Markings business, including potential sales. Leadership changes at the segment and corporate level, such as appointments in finance, operations and Performance Materials, are another recurring theme in company press releases and SEC filings.
In addition, NGVT news has highlighted Ingevity’s role in emerging battery materials through a license agreement with CHASM Advanced Materials for carbon nanotube conductive additives used in battery applications in North America and select European countries. Earnings releases provide detail on segment sales, adjusted EBITDA, cash flow and guidance ranges, giving context on how strategic initiatives and market conditions affect the company’s financial profile. For investors and observers, the NGVT news stream offers insight into how Ingevity is repositioning its portfolio, managing its segments and pursuing opportunities in specialty chemicals and materials.
Ingevity (NYSE: NGVT) reported a decline in first quarter 2024 net sales of $340.1 million, down 13% primarily due to the repositioning of the Performance Chemicals segment. The company incurred a net loss of $56.0 million with diluted loss per share of $1.54, offset by adjusted earnings of $19.1 million and diluted adjusted EPS of $0.52. Ingevity realized cost savings of $20 million in Q1 and aims for $65-75 million in 2024. Full-year guidance includes sales of $1.40-$1.55 billion and adjusted EBITDA between $365-$390 million.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.